Sonali Smith, MD

Associate Professor of Medicine

Dr. Sonali Smith is an expert in the care and treatment of adults with all types of malignant lymphoma. She has a special interest in new agents for lymphoma, as well as stem cell transplantation and its role in improving the survival of patients with relapsed lymphomas.

An active researcher, Dr. Smith is involved in the development of promising agents for patients with non-Hodgkin and Hodgkin lymphoma. She is principal investigator on a number of innovative clinical trials. Many of the trials incorporate the collection of tumor and blood samples to study the effects of treatment on cancer cells through collaborative laboratories.

Practice Location

Center for Advanced Medicine
5758 S. Maryland Avenue
Chicago, IL 60637

Year Started Practice

2001

Board Certifications

Hematology
Internal Medicine
Oncology

Medical School

Northwestern University, Chicago

Residency

Northwestern Memorial Hospital, Chicago

Fellowship

University of Chicago Medical Center

Memberships

American Association for Cancer Research
American Society of Clinical Oncology
American Society of Hematology

Languages Spoken

English
Spanish
Gujarati

Office Phone

(773) 834-2895

Office Fax

(773) 702-3163

Office Postal Address

Sonali Smith, MD
University of Chicago Medical Center
5841 S. Maryland Avenue, MC 2115
Chicago, IL 60637

Clinical Interests

• Lymphoma
• Hodgkin disease
• Stem cell transplant

Request an appointment online
or call HealthLink at
1-888-UCH-0200

Physicians, contact the
Referring Physician Access Line
at 1-877-DOM-2730

Selected Publications

Smith SM, Johnson JL, Niedzwiecki D, Eder JP, Canellos G, Cheson B, Bartlett NL. Sequential topoisomerase I (topo I) and topoisomerase II (topo II) inhibitors in relapsed/refractory aggressive NHL: Results of CALGB 59906, a phase II study of doxorubicin and topotecan. Leukemia & Lymphoma, 2006; 47(8): 1511 – 1517.

Smith SM, Grinblatt D, Cheson B, Bartlett NL. A phase II trial of thalidomide for patients with relapsed or refractory low grade non-Hodgkin’s lymphoma. Br J Haematol. 2008 Feb;140(3):313-9.

Smith SM, van Besien K, Carreras J, Vose JM, Lazarus H, Parameswaren H. Clinical outcome of a second autologous stem cell transplantation for NHL and HL patients relapsing after a first autologous stem cell transplant: An IBMTR analysis. (in press, Biology of Blood and Marrow Transplantation)

Smith SM. Clinical Development of mTOR Inhibitors: A Focus on Lymphoma. Recent Reviews of Clinical Trials, 2007 May 2(2): 103-110(8)